Proactive Investors - Run By Investors For Investors

Midatech Pharma to change iADR ratio to try and bring price into compliance with Nasdaq minimum bid price

For ADR holders, Midatech said the change will have the same effect as a one-for-10 reverse ADR split, with the effective date of the ratio change expected to be 8 April 2019
Shares
The group pointed out that the London-listed ordinary shares of Midatech will not be affected by this change

Midatech Pharma PLC (LON:MTPH) (NASDAQ:MTP) has announced a ratio change on its American Depositary Receipts from one ADR representing two ordinary shares, to a new ratio of one ADR representing twenty ordinary shares.

The AIM-listed R&D company, focused on delivering innovative oncology and rare disease products to patients, said the effective date of the ratio change is expected to be 8 April 2019.

READ: Midatech Pharma soars as Chinese licensing deal is approved

For ADR holders, Midatech said the change will have the same effect as a one-for-10 reverse ADR split.

It added that the change is aimed to bring the price of the company's ADRs into compliance with the Nasdaq US$1.00 minimum bid price per share requirement, though Midatech said it can give no assurance that the ratio change will be effective in achieving this goal.

The company said the number of its ADRs in issue on 18 March 2019 was 8,293,832.

The group pointed out that the London-listed ordinary shares of Midatech will not be affected by this change.

In early morning trading, Midatech shares were up 4.5% at 5.85p.

View full MTPH profile View Profile

Midatech Pharma PLC Timeline

Related Articles

Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system
cancerous cells
March 08 2019
A series of trials underway at major cancer research hospitals are evaluating the company's flagship cancer drug Ampligen
scientist at petrie dish
Wed
Here we take a closer look at Midatech Pharma PLC (LON:MTPH)

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use